| Quarterly Financials | Jun 2021 | Sept 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 17 | 18 | 12 | 16 | 17 | 17 | 15 | 18 | 17 | 18 | 16 | 17 | 18 | 18 | 14 |
| Expenses | 17 | 17 | 11 | 16 | 16 | 16 | 15 | 17 | 16 | 17 | 15 | 17 | 17 | 17 | 14 |
| EBITDA | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Operating Profit % | 4 % | 5 % | 5 % | 2 % | 5 % | 5 % | 3 % | 2 % | 5 % | 3 % | 4 % | 2 % | 5 % | 5 % | 3 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 |
| EPS in ₹ | 0.53 | 0.57 | 0.34 | 0.19 | 0.64 | 0.51 | 0.26 | 0.11 | 0.57 | 0.21 | 0.62 | 0.17 | 1.95 | 0.57 | 0.34 |
Sandu Pharmaceuticals
Sandu Pharmaceuticals
40.70
-1.08
(-2.58%)
Key Fundamentals
Market Cap
39.36 Cr
EPS
1.60
PE Ratio
25.95
Dividend Yield
1.91 %
Industry
Healthcare 52 Week High
62.80
52 Week Low
38.00
PB Ratio
1.21
Debt to Equity
0.00
Sector
Pharmaceuticals Actual
Company News
View All News
Sandu Pharmaceuticals Limited received shareholder approval through postal ballot to reclassify Akshath Finvest and Properties Private Limited from promoter/promoter group to public category, involving 4,94,182 shares representing 5.12% shareholding. The resolution was passed with 92.02% votes in favor, reducing promoter shareholding from 42.90% to 37.79% and increasing public shareholding from 57.10% to 62.21%.
Sandu Pharmaceuticals Publishes Quarterly Financial Results5 days ago
Sandu Pharmaceuticals Limited published its unaudited financial results for the quarter and half year ended September 30, 2025, in newspapers following board approval on November 12, 2025. The company informed the Bombay Stock Exchange about the newspaper publication in Navprabha and Navhind Times dated November 14, 2025, as per SEBI listing regulations.
Sandu Pharmaceuticals Reports No Deviation in Preferential Issue Fund Utilization7 days ago
Sandu Pharmaceuticals Limited submitted a statement to BSE showing no deviation or variation in the utilization of funds raised through preferential issue for the quarter ended September 30, 2025. The company reported on three tranches: first tranche raised Rs 2,63,79,653, second tranche involved conversion of 8,89,667 warrants at Rs 20.69 per warrant raising Rs 1,38,05,408, and third tranche had original allocation of Rs 1,31,94,934 with utilized amount of Rs 1,09,53,914. All funds were allocated for revamping existing capital machinery, developing marketing infrastructure, civil work, plant and machinery purchase, working capital requirements, technology investments and general business enhancement purposes. The Audit Committee reviewed and approved all statements. The company maintains unutilized money in an Escrow account with a fixed deposit created in Bank of Baroda.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,784.10 | #1 4,28,065.35 | 40.27 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 74.53 | |
6,454.00 | 1,71,333.42 | 69.17 | 9,712.00 | 18.67 | 2,191 | 35.10 | 46.81 | |
3,731.40 | 1,26,287.53 | 59.99 | 11,539.40 | 6.99 | 1,911 | 30.46 | 56.17 | |
1,526.80 | 1,23,327.89 | 22.52 | 28,409.50 | 7.12 | 5,291 | 3.71 | 47.29 | |
1,250.20 | 1,04,343.41 | #1 18.09 | 33,741.20 | 16.73 | 5,725 | -0.38 | 54.25 | |
930.20 | 93,599.89 | 18.57 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.90 | |
2,025.40 | 92,511.06 | 21.51 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 57.78 | |
2,223.10 | 91,760.34 | 51.75 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 29.21 | |
1,235.80 | 71,775.46 | 21.23 | 32,345.60 | 9.43 | 3,484 | 3.81 | 74.03 | |
5,724.00 | 68,439.01 | 28.33 | 13,458.30 | 3.70 | 2,216 | 10.98 | 64.07 |
Growth Rate
Revenue Growth
-0.44 %
Net Income Growth
6.67 %
Cash Flow Change
25.00 %
ROE
2.50 %
ROCE
1.37 %
EBITDA Margin (Avg.)
8.21 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 | 2025 |
| Total Assets | 54 | 52 | 56 |
| Fixed Assets | 17 | 18 | 18 |
| Current Assets | 26 | 22 | 26 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 10 | 10 | 11 |
| Other Assets | 28 | 24 | 26 |
| Total Liabilities | 54 | 52 | 56 |
| Current Liabilities | 14 | 11 | 12 |
| Non Current Liabilities | 1 | 1 | 2 |
| Total Equity | 39 | 41 | 42 |
| Reserve & Surplus | 30 | 31 | 32 |
| Share Capital | 10 | 10 | 10 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | 1 | -1 | 0 |
| Investing Activities | 1 | -1 | -0 |
| Operating Activities | 0 | 1 | 1 |
| Financing Activities | 1 | -1 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 45.04 % | 45.04 % | 45.04 % | 48.02 % | 50.43 % | 50.43 % | 50.43 % | 50.43 % | 52.41 % | 52.41 % | 42.90 % | 42.90 % | 42.90 % | 42.90 % | 42.90 % | 42.90 % | 42.90 % | 42.90 % | 42.90 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 51.04 % | 49.67 % | 50.74 % | 46.76 % | 39.89 % | 39.62 % | 39.25 % | 39.28 % | 35.72 % | 35.70 % | 45.29 % | 45.19 % | 44.16 % | 44.25 % | 34.97 % | 35.34 % | 35.90 % | 36.57 % | 36.77 % |
| Others | 3.91 % | 5.28 % | 4.22 % | 5.21 % | 9.67 % | 9.94 % | 10.31 % | 10.28 % | 11.86 % | 11.88 % | 11.81 % | 11.90 % | 12.93 % | 12.84 % | 22.12 % | 21.75 % | 21.20 % | 20.53 % | 20.32 % |
| No of Share Holders | 9,670 | 10,108 | 10,508 | 10,374 | 10,386 | 10,320 | 10,228 | 10,264 | 10,141 | 10,121 | 10,103 | 10,021 | 10,001 | 10,012 | 10,246 | 10,333 | 10,287 | 10,226 | 10,284 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.5 | 0.75 | 0.00 | 0.8 | 0.8 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.71 | 1.43 | 0.00 | 1.63 | 1.91 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 24 Sept 2021 |  Dividend | ₹ 0.50 /share | 22 Sept 2021 | 51.60 | 52.05 |
| 23 Sept 2022 | Dividend | ₹ 0.75 /share | 23 Sept 2022 | 66.00 | 69.35 |
| 19 Sept 2023 | Dividend | ₹ 0.75 /share | 18 Sept 2023 | 55.44 | 78.18 |
| 20 Sept 2024 | Dividend | ₹ 0.80 /share | 19 Sept 2024 | 58.52 | 61.18 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 58.52 | 60.52 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 56.33 | 57.64 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 53.65 | 51.75 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 53.69 | 56.06 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 48.37 | 48.74 |
| 18 Sept 2025 | Dividend | ₹ 0.80 /share | 18 Sept 2025 | 56.06 | 48.79 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 48.74 | 46.87 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 44.25 | 43.14 |
Announcements
: Intimation Regarding Receipt Of Approval Of Shareholders For Reclassification Of M/S Akshath Finvest And Properties Private Limited Persons Forming Part Of The Promoter/Promoter Group Category To The Public Category.
11 hours ago
11 hours ago Shareholder Meeting / Postal Ballot-Scrutinizer"s Report11 hours ago
11 hours agoShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot11 hours ago
11 hours agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication5 days ago
5 days agoStatement Of Deviation And Variation For The Quarter Ended 30.09.20257 days ago
7 days agoUnaudited Financial Results For The Q And Half Year Ended 30.09.20257 days ago
7 days agoBoard Meeting Outcome for Outcome Of The Board Meeting Dated 12.11.20257 days ago
7 days agoBoard Meeting Intimation for Approval Of Standalone Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2025Nov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 18, 2025
Oct 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 18, 2025
Oct 18, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 17, 2025
Oct 17, 2025Approval Of The Draft Postal Ballot Notice And Explanatory StatementOct 14, 2025
Oct 14, 2025Board Meeting Outcome for Outcome Of The Board Meeting Dated 14Th October 2025Oct 14, 2025
Oct 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Board Meeting Intimation for 1. To Approve Notice Of Postal Ballot For Reclassification Of M/S Akshath Finvest And Properties Private Limited From Promoter/ Promoter Group Category To Public Category
Oct 04, 2025
Oct 04, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 01, 2025
Oct 01, 2025Announcement Under Regulation 30-Appointment Of Secretarial AuditorOct 01, 2025
Oct 01, 2025Announcement Under Regulation 30-Update-Agenda Items Approved By Shareholders At The 40Th Annual General MeetingOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Sep 30, 2025Intimation Of Change In E - Mail Address Of Registrar And Share Transfer Agent (RTA) Of The Company.Sep 30, 2025
Sep 30, 2025Intimation To The Holders Of Physical Securities To Furnish PAN And KYC Details As Per SEBI Master Circular Dated June 232025.Sep 30, 2025
Sep 30, 2025Intimation Of Receipt Of No Objection From The Stock Exchanges For Reclassification From Promoter Group Category To Public Category In Accordance With Regulation 30 Read With Regulation 31A(8) Of The SEBI (Listing Obligations And Disclosure Requirements) Sep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 24, 2025
Sep 24, 2025Announcement Under Regulation 30-Update-Show Cause Notice [U/S 9(2) Of The Maharashtra Tax On Professions Trades Callings And Employments Act 1975] Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 08, 2025
Sep 08, 2025Newspaper Publication Post Dispatch Notice Of Annual General Meeting And Evoting InstructionsSep 07, 2025
Sep 07, 2025Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Registered With The Company/RTASep 06, 2025
Sep 06, 2025Notice Of The 40Th Annual General Meeting Of Sandu Pharmaceuticals Limited To Be Held On 30Th September 2025Sep 06, 2025
Sep 06, 2025Reg. 34 (1) Annual Report.Sep 06, 2025
Sep 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 24, 2025
Aug 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 24, 2025
Aug 24, 2025Announcement Under Regulation 30-Update-Newspaper Publication Informing About The 100 Days Campaign - "Saksham Niveshak" Launched By Investor Education And Protection Fund AuthorityAug 20, 2025
Aug 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 15, 2025
Aug 15, 2025Announcement Under Regulation 30-Update-Intimation Of The Conclusion Of Proceeding In Respect Of The Show Cause Notice Received Received From Government Of Maharashtra Department Of Goods And Service Tax As Per Regulation 30 Of The SEBI(Listing ObligatioAug 14, 2025
Aug 14, 2025Intimation About The Record DateAug 13, 2025
Aug 13, 2025Intimation About The Book Closure For The 40Th Annual General MeetingAug 13, 2025
Aug 13, 2025Disclosure Under Regulation 30Aug 13, 2025
Aug 13, 2025Intimation About The Date Of The 40Th Annual General MeetingAug 13, 2025
Aug 13, 2025Complaince Under Reg 32(1)(3) -Statement Of Deviation And Variation Of Funds For Q Ended 30Th June 2025Aug 13, 2025
Aug 13, 2025Unaudited Financials For The Q Ended 30Th June 2025Aug 13, 2025
Aug 13, 2025Board Meeting Outcome for Outcome Of The Board Meeting Dated 13Th August 2025Aug 13, 2025
Aug 13, 2025Announcement Under Regulation 30-Update-Intimation In Respect Of The Refund Order Received From Department Of Commercial Taxes Government Of Goa Office Of Additional Commissioner Of State Taxes -HQ Under Regulation 30 Of The SEBI (Listing Obligations AnAug 11, 2025
Aug 11, 2025Board Meeting Intimation for Approval Of Unaudited Financial Results For Q Ended 30Th June 2025Aug 04, 2025
Aug 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 24, 2025
Jun 24, 2025Announcement Under Regulation 30-Response To Discrepancy Related To Delay In Submission Of Information Regarding Intimation In Respect Of The Show Cause Notice Received From Government Of Maharashtra Department Of Goods And Service Tax Disclosure Under ReJun 04, 2025
Jun 04, 2025Announcement Under Regulation 30-Intimation In Respect Of The Show Cause Notice Received From Government Of Maharashtra Department Of Goods And Service Tax Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) RegulaJun 03, 2025
Jun 03, 2025Intimation Of Submission Of Application For Reclassification Of Person Forming Part Of The Promoter Group Category To Public Category Shareholder Of The Company Pursuant To Regulation 31A Of Securities And Exchange Board Of India (Listing Obligations AndMay 30, 2025
May 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
May 28, 2025Technical Indicators
RSI(14)
Neutral 34.27
ATR(14)
Volatile 2.05
STOCH(9,6)
Neutral 47.02
STOCH RSI(14)
Neutral 28.04
MACD(12,26)
Bearish -0.05
ADX(14)
Strong Trend 35.16
UO(9)
Bearish 50.57
ROC(12)
Downtrend And Accelerating -5.05
WillR(14)
Neutral -54.18
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
